http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2335506-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1d3b6e03a92d64f0e4893a8b297f7647
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04
filingDate 1999-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb8138a5b9d3827aa10abd5db5246f38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_581e8202d4c50a11b5a18ad367fc2885
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f24ef311b26d6a9f7611990502496cf
publicationDate 2000-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2335506-A1
titleOfInvention Mucosal targeting immunisation
abstract The invention concerns the use of an immunogen specific of a pathogenic agent having a gateway in a mucous membrane for producing an immunogenic composition to be administered to a human by parenteral route at the surface of part of the body distinct from the mucous membrane so as to directly develop a local response in IgA, IgG and/or IgM antibody in said mucous membrane.
priorityDate 1998-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450183611
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5359386

Total number of triples: 21.